Augmentin reconsidered.
The antibiotic co-amoxiclav (Augmentin-SmithKline Beecham) was first launched in the UK in 1981. When we reviewed it in 1982, we recommended it as second-line treatment for urinary infections and concluded that its place in other infections was unclear. Here we reassess the value of co-amoxiclav.